SEC Form 4 · accession 0001209191-18-040091
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Barry
Director
Period of report
Jun 27, 2018
Accepted (ET)
Jun 29, 2018 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 27, 2018 | S | 75,000 | $130.34 | D | 3,170,432 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.